Giulia Fiorentini

Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients

Piero Barbanti, Gabriella Egeo, Cinzia Aurilia et al. · The Journal of Headache and Pain · 2022 · 117 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study

Piero Barbanti, Gabriella Egeo, Cinzia Aurilia et al. · The Journal of Headache and Pain · 2023 · 60 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +16

Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study

Piero Barbanti, Cinzia Aurilia, Gabriella Egeo et al. · Journal of Neurology · 2024 · 34 citations · Full text

Life Sciences, Neurology, Pharmacology +17

Very-low-calorie ketogenic diet vs hypocaloric balanced diet in the prevention of high-frequency episodic migraine: the EMIKETO randomized, controlled trial

Massimiliano Caprio, Eleonora Moriconi, Elisabetta Camajani et al. · Journal of Translational Medicine · 2023 · 31 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +12

Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study

Piero Barbanti, Cinzia Aurilia, Paola Torelli et al. · Journal of Neurology · 2025 · 22 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17